1. On the state of sanitary and epidemiological welfare of the population in the Russian Federation in 2016: State report. Moscow: Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing. 2017: 220 (in Russian).
2. Feldblyum I.V. Vaccine prophylaxis of hepatitis B in Russia: the experience of using domestic medical immunobiological drugs. Epidemiologia i Vakcinoprofilaktika. [Epidemiology & Vaccinal Prevention]. 2012; 4 (65): 61 – 67 (in Russian).
3. Sonnov V.N., Shamsheva O.V. Immunogenicity and reactogenicity of the domestic recombinant hepatitis B vaccine in premature infants. Voprosi Hematologii/Oncologiiy and Immunopathologii v Pediatrii. [Pediatric Hematology/Oncology and Immunopathology]. 2010; 3 (9): 26 – 32 (in Russian).
4. Ledin E.V., Akimkin V.G., Rukavitsyn O.A., Skvortsov S.V., Kazakov S.P. Immunological and epidemiological effectiveness of hepatitis B vaccination in patients with oncohematological profile. Voenno-medicinsky zhurnal. [Military Medical Journal]. 2008; 5 (329): 62 – 63 (in Russian).
5. Van Damme P. Hepatitis B: vaccination programmes in Europe-an update. Vaccine. 2001; 19: 2375 – 2379.